In 2019, our group developed a novel silyl ether-based acid-cleavable ADC carrying highly cytotoxic monomethyl auristatin E (MMAE, Fig
Digestion 85:249255
1 The safety profile of RADICAVA ORS was generally consistent across age, race, & gender 1 No overall differences in safety or effectiveness of RADICAVA ORS were observed between geriatric patients over the age of 65 and younger patients, but greater sensitivity of some older individuals cannot be ruled out 1 Low rate of discontinuations due to adverse events (AEs) 3 Only 4 patients discontinued treatment in the first 2 months (4/185)
Who is Methylcobalamin for
To view a copy of this licence, visit About this article Cite this article Ahmed, A.M.A., Osman, S.A
Specific Health Conditions : Certain health conditions, such as chronic liver disease, neurodegenerative disorders, or autoimmune diseases, may influence the choice of glutathione form